Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Review for Herbal Drug and Drug-Induced Liver Injury

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2010, v.31 no.3, pp.128-132
Bong-Ky Park (Daejeon University)

  • Downloaded
  • Viewed

Abstract

Objectives: This study aimed to review the general features of drug induced liver injury (DILI) and the important factors in consideration of herbal drugs and DILI. Methods: We reviewed general aspects of DILI such as classification, inducible factors, diagnosis methods, prevention, and the status of herbal drug-associated DILI via literature. Results: Besides the drug itself, genetic and environmental factors affect hepatic toxicity. There is a lack of definitive diagnoses of DILI by drugs, including herbal remedies. The possibility of herbal drug-associated DILI is exaggerated, and majority of herbal drug-derived hepatic injury could be easily prevented if Oriental doctors pay attention to this issue. Conclusion: This study can provide Oriental doctors an overview and be helpful in minimizing the episodes of hepatotoxicity in use of herbal drugs.

keywords
Drug-induced liver injury, herbal drug, traditional Korean medicine


Reference

1

1 Benedetti MS, Whomsley R, Poggesi I, Cawello W, Mathy FX, Delporte ML, et al. Drug metabolism and pharmacokinetics. Drug Metab Rev. 2009;41(3):344-90.

2

2 Sameshima Y, Shiozaki Y, Mizuno T, Sasakawa M, Suzuki A. Clinical statistics on drug-induced liver injuries: drug-induced liver injuries in Japan in the last 30 years. Jpn J Gastroenterol. 1974; 71(8):799-807.

3

3 Lee WM. Acute liver failure in the Unite states. Semin Liver Dis. 2003;23:217-26.

4

4 Beak JT, Kim MS, Kang SB, Lee SJ, Jang YY, Lee KM, et al. Causative pattern of acute hepatitis in adult last five years. Korean J Int Med. 1999;57(2):352.

5

5 Seo YH, Cho SB, Kim HS, Choi SK, Yoo JS, Kim SJ. Clinical Analysis of 111 Patients by Herbal Medicines and Health Foods. Korean J hepatology. 2001;(2s):S95.

6

6 Kim DJ, An BM, Choe SG, Son JH, Seo JI, Park SH, et al. Study for toxic liver injury in multiple centers. Korean J. hepatology. 2004;10(1):80-6.

7

7 Lee SH, Park JS, Yeo HS, Choi YK, Jun CY, Park CH. Relationship between Herb-medicine and Liver Damage. Korean J Oriental Int Med. 2006;27(3):573-80.

8

8 Kang MH, Sul MC, Moon JY, Lee SH. The clinical study of LFT levels in 117 out-patients while taking herbal medicine for 6 months. Korean J. Oriental Int. Med. 2007;fal(1):105-11.

9

9 Seo1 YJ, Kang SH, Kim YH, Choi DB, Shin HK. Customers' utilization and satisfaction in oriental medical clinics. J Korean Oriental Med 2010; 31(2):124-36.

10

10 Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11(2):272-76.

11

11 An HM. Diagnosis and treatment of drug-induced liver injury. Korean J Hepatology. 2001;7(1s): 45-63.

12

12 Choe HB. Clinical pattern and diagnosis of drug-induced liver injury. Korean J Hepatology. 20014;10(1s):7-18.

13

13 Lucena MI, Garcia-Cortes M, Cueto R, Lopez- Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundamental & Clinical Pharmacology. 2008;22(2):141-58.

14

14 Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004;38 Suppl 2:S44-8.

15

15 Hussaini SH, O'Brien CS, Depott Ej, Dalton HR. Antibiotic therapy a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol. 2007;19(1):15-20.

16

16 Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of druginduced hepatic injuries: a French populationbased study. Hepatology. 2002;36(2):451-5.

17

17 Koff RS, Gardner R, Harinsuta U, Pihl CO. Profile of hyperbilirubinemia in three hospital populations. Clin Res. 1970;18:680.

18

18 Chitturi S, Farrel GC. Drug-induced liver disease. In: Schiff ER, Sorrell MF, Maddrey WC, Ed. Schiff's diseases of liver, vol. 2. 9th ed. Philadelphia: Lippincott Williams & Wilkins. 2003:1059-127.

19

19 Jang IS. A review on the report about drug-induced hepatitis published by the National Institute of Toxicological Research. J Korean Oriental Med. 2004;25(2):78-89.

20

20 Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11): 1323-30.

21

21 Kim DM, Kim HK, Cho SY, Kim YS, Nam SS. Retrospective observation of liver function parameters for 101 patients using herbal drugs for one month. J Korean Oriental Med 2010; 31(2):149-57.

22

22 Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge. J Clin Epidemiol. 1993;46(11): 1331-6.

23

23 Maria VA, Victorino RM, Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26(3): 664-6.

24

24 Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists. World J Gastroenterol. 2007;13(3):329-40.

25

25 Lee SH, Jung HJ, Kim IH, Kim SW. Lee ST, Kim DG. Clinical Experience of Drug-induced Liver Injury in a Single Center. Korean J hepatology. 2005;11(3s):68.

26

26 Woo HJ, Lee JH, Kim YC. Studies on the effects of Puerariae Radix and Artemisiaw Herba on experimental liver damages by alcohol, d-galactosamine and CC$l_{4}$. J Korean Oriental Med 1997; 18(1):411-29.

27

27 An BM. Clinical case and strategy for plantinduced liver injury. Korean J hepatology. 2001; 7(3s):99-110.

28

28 Han CW, Kim SY, Min KS, Lee JH, Lee SH, Youn YS. Incidence of liver function test abnormality among patients hospitalized in an Oriental hospital. J Korean Oriental Med 2010; 31(2):109-13.

29

29 An BM. Herbal preparation-induced liver injury. Korean J Gastroenterol 2004;44(3):113-25.

상단으로 이동

Journal of Korean Medicine